In a controlled trial of a single 2 g. dose of metronidazole (Flagyl) , Csonka (1971) found a cure rate of 82 per cent. (29 of 36 patients) . This compared with a 94 per cent. cure rate (46 of 49 patients) in those treated with 200 mg. three times a day for 7 days. Woodcock (1972) , in a similar trial, found recurrence rates of 15 and 13-7 per cent. respectively in those treated with the new regime and in controls. He commented that whereas a single 2 g. dose of metronidazole appeared to offer satisfactory therapy in women, it did not follow that it would be satisfactory for their consorts.
The present study was designed to test the efficacy of the single 2 g. dosage regime in both females and males. Another six males with trichomoniasis were found during the study period. Two of these men complained of urethral discharge, and the other four had vague genito-urinary symptoms. In five, the positive findings were made at the first examination of urethral discharge or scraping and in the sixth at a second testing; one man also had a positive urethral culture. Table IV shows the procedure which revealed infestation in the total of sixteen men concerned in this study. It is of interest that, in the series of males, both as consorts and as infected patients, the average age is much higher than that of the females and higher than one would expect to find in a group of males with gonorrhoea.
Study of females

Treatment of trichomoniasis with metronidazole 527
The series of males treated is small. Nevertheless the satisfactory results obtained by detailed follow-up testing on three occasions in ten of the sixteen suggests that a single 2 g. dosage regime is highly effective in males with trichomoniasis.
The disparity in recurrence rates between females and males suggests the need for an epidemiologically orientated study of male/female partnerships when both partners are found infested, treated simultaneously, and followed-up by direct microscopy and culture testing.
Summary and conclusions
Of 138 women with vaginal trichomoniasis treated with a single 2 g. dose of metronidazole, 118 were seen for follow-up examination on at least one occasion and 75 had three or more follow-up tests.
There were 21 recurrences (17-8 of those followed). An attempt to define recurrence in terms of treatment failure and re-infection suggests that the true cure rate for this regime may be around 90 per cent.
Sixteen males with trichomoniasis were also treated with a single 2 g. dose of metronidazole.
Ten of these male patients were detected by detailed investigation of a group of 76 consorts of women with trichomonal vaginitis, and six others were found by routine examination of men presenting with genito-urinary symptoms.
Fourteen of the sixteen men treated had at least one follow-up series of tests and ten had three series of detailed tests by microscopy and culture. No recurrences were detected.
It is concluded that a simple 2 g. treatment schedule with metronidazole is adequate treatment for trichomoniasis in both sexes.
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